Immunotherapy Resistance and Therapeutic Strategies in PD-L1 High Expression Non-Small Cell Lung Cancer
OncoTargets and Therapy · 2025-08 · Volume 18 · 953-966
DOI: 10.2147/ott.s539978 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift OncoTargets and Therapy, 2025-08. Verfasst von Jianhua Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Xinghua People's Hospital Affiliated to Yangzhou University, Xinghua, Jiangsu, People's Republic of China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Xinghua People's Hospital Affiliated to Yangzhou University, Xinghua, Jiangsu, People's Republic of China.
- Department of Oncology, Xinghua People's Hospital Affiliated to Yangzhou University, Xinghua, Jiangsu, People's Republic of China.
ORCID-Profile: Jiang Liu
Zitieren
APA
Liu, J., Cai, Y., Liu, J., Chen, D., & Wu, X. (2025). Immunotherapy Resistance and Therapeutic Strategies in PD-L1 High Expression Non-Small Cell Lung Cancer. OncoTargets and Therapy, Volume 18, 953-966. https://doi.org/10.2147/ott.s539978
Vancouver
Liu J, Cai Y, Liu J, Chen D, Wu X. Immunotherapy Resistance and Therapeutic Strategies in PD-L1 High Expression Non-Small Cell Lung Cancer. OncoTargets and Therapy. 2025;Volume 18:953-966. doi:10.2147/ott.s539978
BibTeX
@article{Liu2025,
author = {Liu, Jianhua and Cai, Yin and Liu, Jiang and Chen, Dadong and Wu, Xiang},
title = {Immunotherapy Resistance and Therapeutic Strategies in PD-L1 High Expression Non-Small Cell Lung Cancer},
journal = {OncoTargets and Therapy},
year = {2025},
volume = {Volume 18},
pages = {953--966},
doi = {10.2147/ott.s539978}
}
EUVIMED